Virtual Health Care in a Postpandemic World: Implications for Patients With Neuropituitary Disorders

Published:October 06, 2021DOI:
      COVID-19 has led to significant global changes in clinical practice with several health care providers transitioning to virtual health care (VHC); however, the impact of VHC on patients with neuropituitary tumors remains unclear. We sought to assess the impact of VHC on referral patterns of neuropituitary tumors at our center.


      VHC (virtual health care)
      To read this article in full you will need to make a payment
      AACE Member Login
      AACE Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gatto F.
        • Khorrami K.
        • Nista F.
        • Corica G.
        • Ferone D.
        Acromegaly management in a tertiary referral center after 1 year of the coronavirus 2019 pandemic: a double challenge.
        Endocr Pract. 2021; 27: 856-857
        • Rubin R.
        COVID-19’s crushing effects on medical practices, some of which might not survive.
        JAMA. 2020; 324: 321-323
        • Canadian Medical Association
        Virtual Care in Canada: Discussion Paper.
        (Accessed September 18, 2021.)
        • Bhatia R.S.
        • Chu C.
        • Pang A.
        • Tadrous M.
        • Stamenova V.
        • Cram P.
        Virtual care use before and during the COVID-19 pandemic: a repeated cross-sectional study.
        CMAJ Open. 2021; 9: E107-E114